Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Remission, Spontaneous

sorafenib has been researched along with Remission, Spontaneous in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yao, CA1
Dinçaslan, H; Ensari, A; Kiremitçi, S; Özçakar, ZB; Taktak, A; Yalçınkaya, F; Yılmaz, S1
Iiduka, H; Ishida-Yamamoto, A; Komatsu, S; Minami-Hori, M1
Bogot, N; Grenader, T; Rosenbaum, E; Shavit, L; Zilber, S1

Other Studies

4 other study(ies) available for sorafenib and Remission, Spontaneous

ArticleYear
Sorafenib-induced erythema annulare centrifugum with spontaneous resolution after skin biopsy.
    The Australasian journal of dermatology, 2018, Volume: 59, Issue:2

    Topics: Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Erythema; Humans; Immunohistochemistry; Leg Dermatoses; Liver Neoplasms; Male; Remission, Spontaneous; Skin Diseases, Genetic; Sorafenib

2018
Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
    Pediatric nephrology (Berlin, Germany), 2016, Volume: 31, Issue:6

    Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Ifosfamide; Male; Methotrexate; Nephrotic Syndrome; Niacinamide; Osteosarcoma; Phenylurea Compounds; Proteinuria; Remission, Spontaneous; Sorafenib; Thrombotic Microangiopathies; Vascular Endothelial Growth Factor A; Withholding Treatment

2016
Transient perforating folliculitis induced by sorafenib.
    The Journal of dermatology, 2010, Volume: 37, Issue:9

    Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Folliculitis; Humans; Kidney Neoplasms; Male; Neutrophil Infiltration; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Remission, Spontaneous; Sorafenib

2010
Spontaneous regression of metastatic papillary renal cell cancer after cessation of treatment with sorafenib.
    Clinical genitourinary cancer, 2013, Volume: 11, Issue:2

    Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Remission, Spontaneous; Sorafenib

2013